Respira Therapeutics, Inc.

Form D Filings

Location
Albuquerque, NM
Industry Group
Pharmaceuticals
Entity Type
Corporation
CIK
0001704271
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
4/26/2017 Equity, Option to Acquire $9,105,810 $9,408,000 $302,190 4/11/2017 4/25/2017 D 000170427117000001